China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Why is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. ?

Flat results in Dec 25

OPERATING CASH FLOW(Y) Lowest at CNY 3,006.98 MM
NET PROFIT(9M) At CNY 1,481.3 MM has Grown at -25.77%
DIVIDEND PAYOUT RATIO(Y) Lowest at 0%

With ROE of 15.80%, it has a very attractive valuation with a 2.21 Price to Book Value

Over the past year, while the stock has generated a return of -10.74%, its profits have fallen by -9.2%
At the current price, the company has a high dividend yield of 2.1

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -10.74% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

-11.3%

-0.82

30.27%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.27%

EBIT Growth (5y)

21.54%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.22

Sales to Capital Employed (avg)

1.12

Tax Ratio

17.88%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

21.37%

ROE (avg)

15.25%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.21

EV to EBIT

12.48

EV to EBITDA

9.60

EV to Capital Employed

2.39

EV to Sales

1.58

PEG Ratio

Dividend Yield

2.12%

ROCE (Latest)

19.14%

ROE (Latest)

15.80%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Sideways

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

NET SALES(Q)

Highest at CNY 9,643.07 MM

-11What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 3,006.98 MM

NET PROFIT(9M)

At CNY 1,481.3 MM has Grown at -25.77%

DIVIDEND PAYOUT RATIO(Y)

Lowest at 0%

RAW MATERIAL COST(Y)

Grown by 102.1% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 0 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

DIVIDEND PER SHARE(HY)

Lowest at CNY 0

EPS(Q)

Lowest at CNY 0

Here's what is working for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Net Sales

Highest at CNY 9,643.07 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 9,643.07 MM has Grown at 29.5%

over average net sales of the previous four periods of CNY 7,446.15 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Here's what is not working for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Net Profit

At CNY 1,481.3 MM has Grown at -25.77%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 3,006.98 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

EPS

Lowest at CNY 0

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debt-Equity Ratio

Highest at 0 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 0 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 0 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Dividend per share

Lowest at CNY 0

in the last five years

MOJO Watch

Company is distributing lower dividend than previous years

DPS (CNY)

Dividend Payout Ratio

Lowest at 0%

in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Grown by 102.1% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales